This article provides a neutral comparison of tirzepatide vs semaglutide
interaction p-value=0.689) (Fig
In 2021, the agency approved the drug to help adults and children aged 12 years and older with obesity
Common medications in this class include: Ozempic (semaglutide) Wegovy (semaglutide) Rybelsus (semaglutide) Mounjaro (tirzepatide) Zepbound (tirzepatide) Trulicity (dulaglutide) While many users experience common, milder side effects like nausea, a growing number of individuals are reporting severe, persistent, and life-altering gastrointestinal injuries
Many trials show that people taking semaglutide often experience nausea, vomiting, and stomach discomfort
The findings, many observers noted, highlight the widespread disparities in who has access to the drugs